Skip to main content
. Author manuscript; available in PMC: 2022 Oct 1.
Published in final edited form as: Antiviral Res. 2021 Aug 9;194:105160. doi: 10.1016/j.antiviral.2021.105160

Table 1.

Select hits from KU-HTSL screen.

Compoundsa Percent Inhibition in
Primary Screenb 		Percent Inhibition in
Secondary Screenc
Trichothecenes
KU0188522 100 99
KU0280950 93 95
KU0281790 100 99
KU0281792 99 99
KU0282448 90 91
KU0283070 100 99
KU0283235 98 99
KU0283795 97 97
KU0283847 101 100
 
Lipopeptides
KU0283335 100 99
KU0283824 100 94
 
Cyclin-Dependent Kinase Inhibitors
KU0191030 97 96
KU0190175 90 95
KU0190205 94 96
KU0189256 99 97
KU0190358 99 95
KU0190362 98 96
a

Subgroup of final hits from KU-HTSL screen listed as University of Kansas compound identifiers

b

Percent inhibition of KOS6β from primary screen as described in section 2.4

c

Percent inhibition of KOS6β from secondary screen as described in section 2.5